River Glades Family Offices LLC Abbott Laboratories Transaction History

River Glades Family Offices LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $245,850 - $278,512	-3,750 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $16,004 - $17,664	-278 Reduced 6.9%	3,750 $229,000
Q1 2018 May 10, 2018	BUY	$56.27 - $63.62 $15,643 - $17,686	278 Added 7.41%	4,028 $241,000
Q4 2017 Feb 12, 2018	BUY	$53.68 - $57.47 $201,300 - $215,512	3,750	3,750 $214,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of River Glades Family Offices LLC, based on Form 13F filings with the SEC.

Stay updated on River Glades Family Offices LLC with notifications on news.